Resources

Past Presentation

HCV and People Who Inject Drugs | HCV and SUD Treatment | May 4, 2021

Date of Presentation: May 4, 2021

Type: Past Presentation  

Audience: Clinical  

Program: Ending the Epidemics in Indian Country ECHO Program  

Keywords: #didgwalic  #hcv  #injection drugs  #mat  

In this series of presentations, Jessica Gregg, MD, shares information on HCV in people who inject drugs, and medications used to treat opioid use disorder. Then, Melissa McFarland, MSN, FNP-BC, shares how the didgwálic Wellness Center, owned and operated by the Swinomish Tribe, is overcoming barriers to hepatitis c and substance use disorder treatment to eliminate HCV.

 

Recording:

Presented by:

Dr. Jessica Gregg, Melissa McFarland

Jessica Gregg, MD, PhD, received her undergraduate degree at Stanford University, her medical degree at the University of New Mexico, and a PhD in Medical Anthropology at Emory University. She began her medical career in primary care at Oregon Health and Science University (OHSU), where she co-founded the OHSU Department of Medicine’s Social Medicine curriculum in partnership with City Central Concern, a non-profit caring for individuals struggling with lack of housing and substance use disorders. She subsequently became the medical director for Central City Concern’s Hooper Detoxification and Stabilization Center, and eventually assumed the role of Senior Medical Director for Substance Use Disorder Services for the agency. She subsequently developed the HRBR clinic at OHSU, a low-threshold buprenorphine clinic, and in 2021, she became Chief Medical Officer for De Paul Treatment Centers in Portland, Oregon.

Melissa McFarland, MSN, FNP-BC, received her Master of Science in Nursing degree from Grand Canyon University in 2008 and is board certified in family practice by the American Nurses’ Credentialing Center. Melissa has been a Nurse Practitioner and Associate Medical Director with Didgwalic Wellness Center in Anacortes, WA since 2017 and provides Substance Abuse Treatment, Primary Care and developed leads the Hepatitis C treatment program.

Resources Provided:

Date added: May 4, 2021